U.S. RESEARCH ROUNDUP-Coherent, Huntington Ingalls Industries, Spirit Aerosystems Holdings

Dycom Industries

14/11/2022 07:22

Nov 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Coherent, Huntington Ingalls Industries, and Spirit Aerosystems Holdings, on
Monday. 
    HIGHLIGHTS
                 * Coherent Corp  COHR.O : BofA Global Research raises to buy from neutral
 
                 * Huntington Ingalls Industries  HII.N : BofA Global Research cuts to underperform
 from neutral 
 
                 * Spirit Aerosystems Holdings  SPR.N : BofA Global Research cuts to underperform from
 buy  
 
 Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in
alphabetical order. 
                 * Acadia Pharmaceuticals Inc  ACAD.O : JP Morgan cuts target price to $17 from $19 
 
                 * AN2 Therapeutics Inc  ANTX.O : SVB Securities cuts target price to $25 from $27 
 
                 * Aravive Inc  ARAV.O : Piper Sandler cuts target price to $2 from $6 
 
                 * Beazer Homes USA Inc  BZH.N : Wedbush cuts target price to $18 from $25 
 
                 * Biogen Inc  BIIB.O : Oppenheimer raises target price to $315 from $300 
 
                 * Bright Health Group Inc  BHG.N : Cowen and Company cuts target price to $1 from $2 
 
                 * Bruker Corp  BRKR.O : Cowen and Company cuts target price to $75 from $90 
 
                 * Cadre Holdings Inc  CDRE.N : Stephens raises target price to $32 from $30 
 
                 * Caremax Inc  CMAX.O : Cowen and Company cuts target price to $7 from $9 
 
                 * Clover Health Investments Corp  CLOV.O : Cowen and Company cuts PT to $1.75 from $3 
 
                 * CNH Industrial  CNHI.N : BofA Global Research raises price objective to $17.25 from $14.5 
 
                 * Coherent Corp  COHR.O : BofA Global Research raises to buy from neutral
 
                 * Coherent Corp  COHR.O : BofA Global Research cuts price objective to $45 from $63 
 
                 * Coherus Biosciences Inc  CHRS.O : JP Morgan cuts target price to $11 from $13 
 
                 * Cue Health Inc  HLTH.O : Cowen and Company cuts target price to $7 from $9 
 
                 * Cytek Biosciences Inc  CTKB.O : Piper Sandler raises target price to $18 from $16 
 
                 * Dentsply Sirona Inc  XRAY.O : Jefferies cuts target price to $37 from $45 
 
                 * Dycom Industries Inc  DY.N : Wells Fargo cuts target price to $120 from $130 
 
                 * Edgewell Personal Care Co  EPC.N : Jefferies cuts target price to $40 from $41 
 
                 * Elanco Animal Health Inc  ELAN.N : Piper Sandler cuts target price to $15 from $21 
 
                 * Exact Sciences Corp  EXAS.O : Piper Sandler raises target price to $50 from $40 
 
                 * Expensify Inc  EXFY.O : JP Morgan cuts target price to $20 from $25 
 
                 * Fulgent Genetics Inc  FLGT.O : Piper Sandler cuts target price to $65 from $70 
 
                 * Gain Therapeutics Inc  GANX.O : BTIG cuts target price to $10 from $30 
 
                 * Goodrx Holdings Inc  GDRX.O : Cowen and Company cuts target price to $6.5 from $9 
 
                 * Heska Corp  HSKA.O : Piper Sandler cuts target price to $165 from $170 
 
                 * Homology Medicines Inc  FIXX.O : Credit Suisse cuts target price to $2.1 from $3.21 
 
                 * Huntington Ingalls Industries  HII.N : BofA Global Research cuts to underperform from neutral 
 
                 * Illumina Inc  ILMN.O : Piper Sandler cuts target price to $300 from $320 
 
                 * Innovage Holding Corp  INNV.O : Cowen and Company raises target price to $7 from $6 
 
                 * Jasper Therapeutics Inc  JSPR.O : Oppenheimer cuts target price to $8 from $21 
 
                 * Lifestance Health Group Inc  LFST.O : Cowen and Company cuts target price to $8 from $10 
 
                 * Liveone Inc  LVO.O : Alliance Global Partners cuts target price to $3.5 from $5 
 
                 * Mid Penn Bancorp Inc  MPB.O : Stephens raises target price to $37 from $33 
 
                 * Neogenomics Inc  NEO.O : Piper Sandler cuts target price to $18 from $19 
 
                 * Oncocyte Corp  OCX.O : Piper Sandler cuts target price to $1 from $1.5 
 
                 * Oscar Health Inc  OSCR.N : Cowen and Company cuts target price to $3 from $8 
 
                 * Protagonist Therapeutics Inc  PTGX.O : BTIG cuts target price to $41 from $45 
 
                 * Rain Therapeutics Inc  RAIN.O : Jonestrading raises target price to $20 from $17 
 
                 * Science 37 Holdings Inc  SNCE.O : Cowen and Company cuts target price to $3 from $7 
 
                 * Spirit Aerosystems Holdings  SPR.N : BofA Global Research cuts to underperform from buy 
 
                 * Spirit Aerosystems Holdings  SPR.N : BofA Global Research cuts price objective to $26 from $49 
 
                 * Spirit Aerosystems Holdings  SPR.N : JP Morgan cuts target price to $40 from $45 
 
                 * Surgery Partners Inc  SGRY.O : Cowen and Company cuts target price to $35 from $39 
 
                 * Traeger Inc  COOK.N : Piper Sandler raises target price to $6 from $5 
 
                 * Transdigm Group Inc  TDG.N : Jefferies cuts target price to $720 from $780 
 
                 * Triumph Group Inc  TGI.N : Jefferies cuts target price to $19 from $20 
 
                 * TTEC Holdings Inc  TTEC.O : Cowen and Company cuts target price to $44 from $46 
 
                 * Vor Biopharma Inc  VOR.O : Oppenheimer cuts target price to $18 from $27 
 
                 * Whitestone REIT  WSR.N : Colliers Securities cuts target price to $13 from $14 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))